Delirium Phenotypes and Subsequent Impairment During Transition From ICU to Hospital Wards
NCT ID: NCT07193797
Last Updated: 2025-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
189 participants
OBSERVATIONAL
2024-03-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* What is the main rehabilitation problem during transition from ICU to hospital wards for patients who experienced ICU delirium?
* Dose different phenotypes of ICU delirium shows different rehabilitation problem during ICU transition? Participants will be followed up and assessed by questionnaires after discharge from ICU to hospital wards until hospital discharge.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Trajectory and Influencing Factors of Cognitive Level in ICU Delirium Patients After Transfer Out of the ICU
NCT06674603
Prevention of Delirium in ICU Using Multimodal Interventions
NCT05950958
Incidence and Risk Factors of PostopeRativE Delirium in ICU in China
NCT03704324
Postoperative Delirium in Cardiac Surgery ICU
NCT04527341
The ICU DElirium in Clinical PracTice Implementation Evaluation Study Screening and Treatment
NCT01952899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU delirium cohort
Phenotypes of ICU delirium
The included delirium patients will be divided into different phenotypes, according to delirium risk factors such as age, history of cerebrovascular accident, blood transfusion, surgery duration etc.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phenotypes of ICU delirium
The included delirium patients will be divided into different phenotypes, according to delirium risk factors such as age, history of cerebrovascular accident, blood transfusion, surgery duration etc.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least one positive screening of CAM-ICU (Confusion Assessment Method for ICU) assessment during ICU stay
* patients are transferred to hospital ward after ICU discharge
Exclusion Criteria
* blindness, deafness or inability to understand mandarin
* life expectancy of less than 24h
* stayed in ICU more than one-month after the first CAM-ICU positive screening
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Natural Science Foundation of China
OTHER_GOV
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shining Cai
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NSFC-7220040527
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.